Dr. Julien Ringuet

Dermatologist, Quebec City, QC

Dr. Ringuet is a board-certified dermatologist who practices in Quebec City with a focus on clinical trials.
After his bachelor degree in biology, Dr. Ringuet completed his medical training (MD) at Laval University in Quebec City. He also performed his post graduate studies in dermatology in his alma mater from which he graduated in 2020. Additionally, and considering his keen interest in research, Dr. Ringuet completed throughout his medical training a master in experimental medicine (MSc) in the field of skin bioengineering at the Centre de Recherche en Organogénèse Expérimentale de l’Université Laval (LOEX).
In collaboration with the center founder, Dr. Yves Poulin, Dr. Ringuet now leads his dedicated team of the Centre de Recherche Dermatologique du Québec Métropolitain (CRDQ) in allowing Quebec’s patients to access top quality and innovative clinical research focused on dermatological diseases. Dr. Ringuet’s research interest are mainly psoriasis and its variants, atopic dermatitis, vitiligo and alopecia areata.
"

10:00 AM - 10:45 AM Open Session

Friday NOV 25, 2022

Deucravacitinib Open Session: PsO Who Are You?

Learning Objectives:

  1. Differentiate TYK2 inhibitors from JAK inhibitors
  2. Identify patients with moderate-to-severe psoriasis who are candidates for oral TYK2 inhibitors based on their disease characteristics and medical history
  3. Apply practical skills to managing patients on TYK2 inhibitors

Summary:
PsO Who Are You is the extraordinary dermatology conference challenge that provides compelling education for all dermatologists!
THE OBJECT OF THE GAME is to discover the answer to three questions related to the use of existing and emerging oral therapies:
WHO are the patients using oral systemic therapies?
WHAT is their medical and treatment history prior to starting an oral therapy?
WHY is an oral therapeutic an appropriate option for those patients?
THE GAME BOARD features three stellar dermatologists: Dr. David Adam, Dr. Perla Lansang, and Dr. Julien Ringuet. Of the many possible patient scenarios, each opponent will present one character who is eligible for advanced oral therapies.
THE GAME PLAY will begin with each opponent taking turns posing questions on medical history and treatment considerations in order to reveal the details of the patient case.
THE GAME ENDS when one opponent correctly guess the patient description based on the clues given throughout the presentation.
Three dermatologists, three patient profiles. Let the game begin!